Study: Roflumilast cream 0.05% is safe, effective in young children with eczema
Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in Pediatric Dermatology.
HealthDay on MSN11d
AAD: Maintenance of Low Eczema Activity Seen After About 80 Days Off Tapinarof
Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low dise ...
HealthDay11d
Roflumilast Cream 0.05 Percent Safe, Effective in Young Children With Eczema
Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 ye ...